Tenax Therapeutics (NASDAQ:TENX) Earns Buy Rating from Analysts at Guggenheim
Guggenheim started coverage on shares of Tenax Therapeutics (NASDAQ:TENX – Free Report) in a research report report published on Monday, MarketBeat reports. The firm issued a buy rating and a $16.00 price target on the specialty pharmaceutical company’s stock. Other equities research analysts have also recently issued research reports about the stock. William Blair began […]
More Stories
F & M Bank (OTCMKTS:FMBM) Stock Price Passes Above 50 Day Moving Average – What’s Next?
F & M Bank Corp. (OTCMKTS:FMBM – Get Free Report) crossed above its 50 day moving average during trading on...
Country Garden (OTCMKTS:CTRYY) Share Price Crosses Above 50-Day Moving Average – What’s Next?
Country Garden Holdings Company Limited (OTCMKTS:CTRYY – Get Free Report)’s stock price crossed above its 50 day moving average during...
Kestrel Gold (CVE:KGC) Share Price Passes Above Fifty Day Moving Average – What’s Next?
Shares of Kestrel Gold Inc. (CVE:KGC – Get Free Report) crossed above its fifty day moving average during trading on...
PureTech Health (LON:PRTC) Share Price Crosses Above 50-Day Moving Average – Here’s What Happened
PureTech Health plc (LON:PRTC – Get Free Report)’s share price passed above its 50 day moving average during trading on...
StockNews.com Upgrades Regal Rexnord (NYSE:RRX) to “Buy”
Regal Rexnord (NYSE:RRX – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in...
Charles Schwab (NYSE:SCHW) PT Raised to $74.00 at The Goldman Sachs Group
Charles Schwab (NYSE:SCHW – Get Free Report) had its price target lifted by stock analysts at The Goldman Sachs Group...